Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks
Swiss Cancer Institute
Swiss Cancer Institute
University College, London
HTA Co., Ltd.
Alliance for Clinical Trials in Oncology
Amgen
Alliance for Clinical Trials in Oncology
Johns Hopkins Bloomberg School of Public Health
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group
Virginia Commonwealth University
INSYS Therapeutics Inc
Amgen
Institut Paoli-Calmettes
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.